Miscarriages and preterm birth (PTB) can be a difficult experience for expectant mothers, and many seek out positive support systems to help cope. As the world has become more digital, social media has become a support system for women who have experienced these events, according to new research published in Paediatric and Perinatal Epidemiology.
The study aimed to better understand how Twitter users discuss the topics of miscarriage and PTB, analyze the trends and drivers, and describe the perceived emotional state of women who have experienced a miscarriage.
The authors obtained 291,443 Twitter posting on miscarriages and preterm births from January 2017 through December 2018. They applied Latent Dirichlet Allocation (LDA) to identify major topics in the data. LDA models are used for uncovering latent topics within a large set of text.
Words are assigned weights within particular topics given assumed probability distributions. The authors also used time series decomposition methods to assess temporal trends and identify major conversation drivers. In order to determine the emotional content of 7282 personal miscarriage disclosure tweets, the authors classified the tweets into six non-mutually exclusive categories: grief/sadness/depression, anger, relief, isolation, annoyance, and neutral.
Based on their findings, the authors discovered that the topics in their data fell into eight groups: celebrity disclosures, Michelle Obama’s disclosure, politics, healthcare, preterm births, loss and anxiety, flu vaccine and ectopic pregnancies.
However, they noted that the political discussions around miscarriages were largely a result of a misunderstanding between abortions and miscarriages. Within miscarriage disclosures, grief and annoyance were the emotions most commonly expressed by users 50.6% (95%CI 49.1 – 52.2) and 16.2% (95% CI 15.2 to 17.3), respectively.
The authors also noted that postings increased with celebrity disclosures; celebrities were considered strong and brave for publicly discussing the topic and Michelle Obama’s disclosure generated substantial response. These celebrity disclosures also led to increased disclosures by women who had similar experiences.
For example, Obama’s disclosure resulted in a response approximately 3.6 times higher than the weekly average of postings in 2018. Postings also increased with pharmacists’ refusal of prescribed medications and with outrage over the high rate of preterm births in the United States.
Based on the results of their study, the authors believe that celebrity disclosures lead to the biggest increase in discussions of miscarriage on social media. They also believe that the results provide an insight of current public perceptions of miscarriage and illustrate how individuals use Twitter to share information and/or seek support.
A better understanding of how individuals who have experienced miscarriage use social media may be informative for clinicians who provide miscarriage care and treatment.
Cesare, N., Oladeji, O., Ferryman, K., Wijaya, D., Hendricks, Muñoz, K. D., Ward, A., & Nsoesie, E. O. (2020). Discussions of miscarriage and preterm births on Twitter. Paediatr. Perinat. Epidemiology. doi: 10.1111/ppe.12622
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
2 Commerce Drive
Cranbury, NJ 08512